Carman Alenson is CAO at AGIOS PHARMACEUTICALS, INC. (AGIO). They have made 7 open-market trades across 1 company since 2018, most recently 2021-06-21.
CIK 0001688865
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 7 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| AGIO | 1,777 | $56K |
Shares reported on the most recent Form 4, priced at the 2021-06-23 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| AGIO | SELL | 2021-06-21 | 2021-06-23 | $61.61 | $219K | +1.5% | -11.1% | -16.7% |
| AGIO | SELL | 2021-04-16 | 2021-04-20 | $55.89 | $125K | +0.7% | +2.4% | +1.6% |
| AGIO | SELL | 2021-04-15 | 2021-04-16 | $54.00 | $54K | +2.4% | +2.9% | +3.6% |
| AGIO | SELL · 10b5-1 | 2020-09-02 | 2020-09-04 | $39.93 | $10K | -3.8% | -9.6% | +12.6% |
| AGIO | SELL · 10b5-1 | 2020-03-02 | 2020-03-04 | $47.30 | $16K | -30.5% | -20.0% | +11.5% |
| AGIO | SELL · 10b5-1 | 2020-02-26 | 2020-02-28 | $47.12 | $22K | -13.6% | -25.2% | +12.8% |
| AGIO | SELL | 2020-02-20 | 2020-02-24 | $53.37 | $259K | -2.2% | -24.8% | +5.6% |
| AGIO | SELL | 2019-12-26 | 2019-12-30 | $50.09 | $296K | +1.4% | +11.6% | -25.7% |
| AGIO | SELL | 2018-09-28 | 2019-02-20 | $76.45 | $12K | +17.7% | +8.6% | -10.4% |
| AGIO | SELL · 10b5-1 | 2018-09-05 | 2018-09-07 | $83.00 | $26K | -5.5% | -11.2% | -26.7% |
| AGIO | SELL · 10b5-1 | 2018-07-09 | 2018-07-11 | $84.94 | $23K | +4.4% | -11.6% | -23.8% |
| AGIO | SELL | 2018-01-12 | 2018-01-26 | $75.00 | $161K | -3.1% | +2.7% | +6.9% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.